C 
China Reform Health Management and Services Group Co 000503.SZ · CNY
Health Care · Shenzhen · 🇨🇳 China
6.89
-1.85%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥350.4m
FY2016FY2025
Net income
−CN¥404.0m
FY2016FY2025
Free cash flow
−CN¥127.3m
FY2016FY2025
Shareholders' equity
CN¥1.01bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥350.4m | CN¥356.9m | CN¥330.1m | CN¥311.1m | CN¥252.5m | CN¥207.4m | CN¥129.9m | CN¥95.5m | CN¥99.0m | CN¥216.8m |
| Research and development | CN¥2.8m | CN¥339,291 | CN¥967,945 | CN¥9.6m | CN¥16.3m | CN¥16.4m | CN¥5.8m | CN¥865,258 | CN¥18.2m | CN¥10.8m |
| Operating income | −CN¥141.8m | −CN¥15.8m | −CN¥82.7m | −CN¥84.5m | −CN¥176.4m | −CN¥241.7m | CN¥16.1m | −CN¥182.6m | CN¥6.8m | CN¥24.8m |
| Net income | −CN¥404.0m | −CN¥10.4m | −CN¥79.8m | −CN¥84.3m | −CN¥175.8m | −CN¥242.6m | CN¥17.4m | −CN¥187.8m | CN¥16.7m | CN¥28.0m |
| Diluted earnings per share | -0.41 | -0.01 | -0.08 | -0.09 | -0.19 | -0.27 | 0.02 | -0.21 | 0.02 | 0.03 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥1.80bn | CN¥2.06bn | CN¥1.95bn | CN¥1.10bn | CN¥1.19bn | CN¥1.30bn | CN¥1.31bn | CN¥1.28bn | CN¥1.45bn | CN¥1.49bn |
| Cash and short-term investments | — | CN¥1.31bn | CN¥1.38bn | CN¥589.4m | CN¥756.7m | CN¥938.8m | CN¥809.7m | CN¥739.5m | CN¥706.7m | CN¥1.04bn |
| Total liabilities | CN¥791.9m | CN¥656.3m | CN¥530.2m | CN¥391.7m | CN¥405.1m | CN¥332.6m | CN¥77.7m | CN¥62.7m | CN¥55.6m | CN¥79.1m |
| Debt | CN¥47.0m | CN¥261.7m | CN¥190.9m | CN¥55.1m | CN¥49.7m | CN¥50.1m | −CN¥17.7m | — | CN¥65,440 | CN¥830,271 |
| Shareholders' equity | CN¥1.01bn | CN¥1.41bn | CN¥1.42bn | CN¥711.4m | CN¥785.6m | CN¥961.1m | CN¥1.22bn | CN¥1.21bn | CN¥1.41bn | CN¥1.42bn |
| Shares outstanding | 975m | 979m | 948m | 905m | 907m | 899m | 898m | 899m | 899m | 898m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −CN¥81.7m | −CN¥82.5m | −CN¥102.2m | −CN¥160.2m | −CN¥104.8m | −CN¥93.0m | CN¥66.0m | −CN¥23.2m | −CN¥241.5m | CN¥22.9m |
| Capital spending | −CN¥45.7m | −CN¥37.6m | −CN¥52.1m | −CN¥37.7m | −CN¥23.1m | −CN¥17.7m | −CN¥32.5m | −CN¥37.5m | −CN¥93.2m | −CN¥109.7m |
| Free cash flow | −CN¥127.3m | −CN¥120.1m | −CN¥154.3m | −CN¥197.9m | −CN¥127.9m | −CN¥110.7m | CN¥33.5m | −CN¥60.7m | −CN¥334.7m | −CN¥86.7m |
| Dividends paid | −CN¥5.8m | −CN¥6.9m | −CN¥4.6m | −CN¥1.4m | −CN¥1.7m | −CN¥623,486 | −CN¥623,486 | −CN¥214 | −CN¥2.7m | −CN¥65,074 |
Latest quarters
By quarter end
| Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥64.1m | CN¥51.0m | CN¥50.5m | CN¥180.0m | CN¥74.9m | CN¥45.1m | CN¥50.5m | CN¥156.7m |
| Operating income | −CN¥44.8m | −CN¥48.7m | −CN¥50.1m | CN¥4.1m | −CN¥44.1m | −CN¥53.4m | −CN¥44.9m | CN¥21.5m |
| Net income | −CN¥40.4m | −CN¥53.6m | −CN¥48.6m | −CN¥265.6m | −CN¥39.3m | −CN¥53.5m | −CN¥45.6m | CN¥20.6m |
| Diluted earnings per share | -0.04 | -0.06 | -0.05 | -0.27 | -0.04 | -0.05 | -0.05 | 0.02 |
| Cash from operations | — | — | — | — | −CN¥63.0m | −CN¥53.0m | −CN¥65.0m | — |
| Capital spending | −CN¥7.0m | −CN¥10.0m | −CN¥5.0m | −CN¥16.0m | −CN¥10.0m | −CN¥9.0m | −CN¥8.0m | −CN¥2.0m |
| Free cash flow | — | — | — | — | −CN¥73.0m | −CN¥62.0m | −CN¥73.0m | — |
| Total assets | CN¥1.56bn | CN¥1.67bn | CN¥1.75bn | CN¥1.80bn | CN¥2.01bn | CN¥2.02bn | CN¥1.99bn | CN¥2.06bn |
| Cash and short-term investments | — | — | — | — | CN¥1.13bn | CN¥1.12bn | CN¥1.23bn | CN¥1.31bn |
| Debt | — | CN¥52.0m | CN¥47.0m | CN¥47.0m | CN¥271.6m | CN¥253.9m | CN¥146.1m | CN¥140.1m |
| Shareholders' equity | CN¥1.08bn | CN¥1.12bn | CN¥959.2m | CN¥1.01bn | CN¥1.27bn | CN¥1.31bn | CN¥1.36bn | CN¥1.41bn |
Financial ratios
Data as of 8 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | -112.2% | -45.5% | -35.9% | -35.3% | -58.1% | -62.4% |
| Net margin | -115.3% | -2.9% | -24.2% | -27.1% | -69.6% | -117.0% |
| Return on equity | -40.1% | -0.7% | -5.6% | -11.9% | -22.4% | -25.2% |
| Return on assets | -22.4% | -0.5% | -4.1% | -7.6% | -14.7% | -18.7% |
| Free cash flow yield | -0.5% | -0.6% | -0.7% | -1.7% | -1.1% | -1.1% |
| Revenue growth | -1.8% | 8.1% | 6.1% | 23.2% | 21.8% | 59.6% |
| Earnings growth | 3793.7% | -87.0% | -5.4% | -52.0% | -27.5% | -1492.1% |
| Current ratio | 2.03x | 3.02x | 3.01x | 2.00x | 2.18x | 3.10x |
| Debt to equity | 0.05x | 0.10x | 0.13x | 0.06x | 0.04x | 0.05x |
| Equity ratio | 56.0% | 68.2% | 72.8% | 64.4% | 65.9% | 74.1% |
| Interest coverage | -36.15x | -18.84x | -22.38x | -50.29x | -42.07x | -192.39x |
| R&D as a share of sales | 0.8% | 0.1% | 0.3% | 3.1% | 6.5% | 7.9% |
| Buybacks as a share of market value | 0.5% | -3.3% | -4.8% | 0.3% | -1.0% | -0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 4.1% | 11.1% | 6.1% |
| Operating income | 18.8% | -10.1% | — |
| Net income | 68.6% | 10.7% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -22.3% | -24.1% | -41.1% | -33.0% |
| Net margin | -58.6% | -42.9% | -55.1% | -43.2% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -21.4 | -1036.5 | -156.6 | -109.0 | -87.2 | -31.0 | — | -76.1 | — | — |
| Price to sales | 24.7 | 30.1 | 37.8 | 29.6 | 60.7 | 36.2 | 118.4 | 149.6 | 392.0 | 174.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 31 May 2004.
| FY2004 | FY2001 | FY1995 | |
|---|---|---|---|
| Paid in the year | 0.083 | 0.013 | 0.083 |
- 6-for-5 split · 10 Jun 2011
- 1-to-1 reverse split · 16 May 2006
- 2-for-1 split · 31 May 2004
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.